Wednesday, 25 March 2026
  
Login

Australia's most trusted
source of pharma news

Wednesday, 25 March 2026
News

PBS giant hangs on tight

Posted 25 March 2026 AM

Australia is a bright spot for megablockbuster drug and Top 10 PBS earner, Eliquis, which is facing a patent cliff this year in Europe, and in the United States in 2028.

GlobalData said the anti-coagulant, sponsored in Australia by BMS but co-developed with Pfizer, peaked last year with global sales just under US$14.2 billion after recording a compound annual growth rate of 108.3 per cent since it launched in Europe in 2011.

To see the whole article, please login

Popular

Where Drs say pharma falls short
Ex-J&J staffer sued for secrets 'theft'
Fresh fallout from PBAC rejections
Call out for Aussie innovators
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home